engleski

COVID-19 - is the ACE2 just a foe?

I read with great interest and pleasure the recent editorial article "Covid-19 infection 31 and mortality – A physiologist's perspective enlightening clinical features and plausible interventional 32 strategies" by Abassi ZA and colleagues (1). In the article, the authors suggested blockage of 33 angiotensin-converting enzyme 2 (ACE2) as a potential strategy for mitigating clinical picture and 34 reducing mortality in SARS-CoV-2 infected subjects

COVID-19 ; ACE2 ; RAS ; SARS-Cov-2 ; lung injury

nije evidentirano